Specialists Step Up To Offer Revolutionary Shockwave Therapy

Issue 19

A revolutionary therapy is being offered in Newcastle thanks to an innovative partnership between physiotherapy practice Physiotherapy Matters and chiropody and podiatry specialist Newcastle Foot Clinic.

The health specialists have joined forces to offer extracorporeal shockwave therapy (ESWT) to a wide range of patients in the North East who suffer from chronic and painful musculoskeletal conditions. In the past, this treatment has only been available to professional athletes.

ESWT is a non-invasive, specialist treatment that works by passing a very low energy shockwave through the affected area, helping to initiate a healing response. The National Institute for Health and Clinical Excellence (NICE) has recommended it as an effective treatment option for a number of conditions including plantar fasciitis, achilles tendinopathy, greater trochanteric pain syndrome, tennis elbow and calcific shoulder tendinitis.

The ESWT is performed using the state-of-the-art Swiss Dolorcast Master, a radial shock wave therapy machine, on which the teams at both Physiotherapy Matters and Newcastle Foot Clinic are fully-trained. The treatment typically consists of 3-4 sessions and is routinely offered alongside a rehabilitation program.

Launched in 2006, Physiotherapy Matters’ qualified industry professionals deliver pioneering physiotherapy, acupuncture and injection treatments across the full range of musculoskeletal injuries and diseases.

Established in 2003, Newcastle Foot Clinic specialises in chiropody and podiatry services such as orthotics and biomechanical assessments, treating a range of lower limb and foot ailments.

Neeraj Nayyar, Managing Director of Physiotherapy Matters, said: “We are delighted to be partnering with Newcastle Foot Clinic to give our patients access to this revolutionary technology. We feel that we can make a real difference to people suffering from many different ailments which can have a detrimental effect on their daily lives.”

Sign-up to our newsletter

  • This field is for validation purposes and should be left unchanged.